Both CD103 and CD69 limit T cell tissue egress by downregulation of several chemotaxis regulators (e.g., S1RP1 and KLF2) and receptors (KLRG1) and are crucial determinants of TRM retention in epithelial tissues, including breast tumors. The gene discussed is CD69; the disease is breast neoplasm.